NYSE:PFE Pfizer stock price forecast, Buy Breakout, Target 68.45Pfizer (NYSE: PFE)
Trade : Buy Breakout
Entry : 42.84
Target : 68.45 (25.61, +59.78%)
Stop : 37 (-5.84, -13.63%)
Posted on Sunday, December 13, 2020
Note : Pharmaceutical stocks are drawing attention in connection with the COVID-19 (Coronavirus disease 2019) vaccine. Pfizer is one of them. There is no COVID-19 vaccine yet that everyone recognize the efficacy, and it is not known how long it will take. In other words, the prices of pharmaceutical stocks related to the COVID-19 vaccine could not be assured. Pfizer stock prices fell after hitting the resistance line of 42.84. If they strongly break out that price line again, it would be a sign of rise. In that case, the next resistance(target) could be 56.12 and 68.45. If the pharmaceutical market is very strong, we may see 99 or so. It would be better to find opportunities to buy when its stock price breaks out 42.84.
PFE trade ideas
PFE/USD_WeeklyEven though PFE was rejected from the $41.50 level on the weekly, there's more room to the upside in MHO. Seems to me that there's a little more room to grow, keeping in mind that there may be a major announcement coming soon.
Levels that I'm watching at the moment: $37.20 and $35.20 to the downside; $43.90 to $45.70 to the upside
Classic Cup and Handle formation - bullishFundamentals are lining up for this mega cap biotech. Pfizer, an international household for medicine and vaccines will be the biggest distributor of Covid-19 vaccines. Having the precedence of UK emergency approval, there is only upside for this name as they rollout vaccines to the rest of the world. We see every dip as a buy opportunity.